Ma Yuxiang
Specialist in Lung Cancer
International patient consultation support
Ma Yuxiang, Specialist in Lung Cancer, is listed in MedToChina's specialist directory through Sun Yat-sen University Cancer Center. MedToChina helps overseas patients organize records, translate core medical documents, and prepare clear appointment questions before a hospital or physician review.
For cases related to Lung Cancer, our team can help check which records, scans, pathology reports, lab results, and treatment summaries may be needed before requesting a consultation.
Before requesting an appointment
- Recent diagnosis and treatment history
- Imaging, lab, pathology, or discharge reports
- Current medications and allergies
- Preferred travel window and city constraints
MedToChina coordinates communication, translation, and logistics only. Diagnosis, treatment decisions, and medical advice must come from licensed clinicians.
Planning guides
Prepare a stronger consultation request
Second opinion records
Prepare the case summary, images, reports, and focused questions hospitals need for review.
China hospital appointment guide
Learn how overseas patients can prepare records and appointment questions for Chinese hospitals.
Prepare for treatment in China
Organize the practical steps before consultations, admission, recovery, and follow-up communication.
FAQ
Consultation planning questions
Can international patients request a consultation with Ma Yuxiang?
A request can be prepared for hospital or physician review, but availability, department routing, and clinical suitability depend on the hospital's assessment of the patient's records.
What records should be prepared for Ma Yuxiang's review?
A diagnosis timeline, recent reports, source images where relevant, medication history, prior treatment summaries, and focused questions help the hospital decide the next step.
Does MedToChina provide diagnosis or treatment advice?
No. MedToChina provides coordination, translation, record preparation, and travel support only. Medical advice and treatment decisions must come from hospitals and licensed clinicians.